Zhejiang Hengtong HoldingLtd Second Quarter 2024 Earnings: EPS: CN¥0.02 (vs CN¥0.056 in 2Q 2023)
Zhejiang Hengtong HoldingLtd (SHSE:600226) Second Quarter 2024 Results
Key Financial Results
- Revenue: CN¥356.0m (up 134% from 2Q 2023).
- Net income: CN¥53.4m (down 20% from 2Q 2023).
- Profit margin: 15% (down from 44% in 2Q 2023). The decrease in margin was driven by higher expenses.
- EPS: CN¥0.02 (down from CN¥0.056 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Zhejiang Hengtong HoldingLtd shares are down 5.8% from a week ago.
Risk Analysis
Before you take the next step you should know about the 1 warning sign for Zhejiang Hengtong HoldingLtd that we have uncovered.
Valuation is complex, but we're here to simplify it.
Discover if Zhejiang Hengtong HoldingLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:600226
Zhejiang Hengtong HoldingLtd
Researches and develops, produces, and sells biological pesticides, veterinary drugs, and animal feed additive products in People's Republic of China and internationally.
Adequate balance sheet with questionable track record.